BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37857782)

  • 21. Unilateral vestibular schwannoma in a patient with schwannomatosis in the absence of LZTR1 mutation.
    Mehta GU; Feldman MJ; Wang H; Ding D; Chittiboina P
    J Neurosurg; 2016 Dec; 125(6):1469-1471. PubMed ID: 26848914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
    Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
    Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple schwannomas of the upper limb related exclusively to the ulnar nerve in a patient with segmental schwannomatosis.
    Molina AR; Chatterton BD; Kalson NS; Fallowfield ME; Khandwala AR
    J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):e376-9. PubMed ID: 23810216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2.
    Wolkenstein P; Benchikhi H; Zeller J; Wechsler J; Revuz J
    Dermatology; 1997; 195(3):228-31. PubMed ID: 9407167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurofibromatoses. Part 2: NF2 and schwannomatosis.
    Lu-Emerson C; Plotkin SR
    Rev Neurol Dis; 2009; 6(3):E81-6. PubMed ID: 19898272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schwannomatosis: a genetic and epidemiological study.
    Evans DG; Bowers NL; Tobi S; Hartley C; Wallace AJ; King AT; Lloyd SKW; Rutherford SA; Hammerbeck-Ward C; Pathmanaban ON; Freeman SR; Ealing J; Kellett M; Laitt R; Thomas O; Halliday D; Ferner R; Taylor A; Duff C; Harkness EF; Smith MJ
    J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1215-1219. PubMed ID: 29909380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas.
    Patil S; Perry A; Maccollin M; Dong S; Betensky RA; Yeh TH; Gutmann DH; Stemmer-Rachamimov AO
    Brain Pathol; 2008 Oct; 18(4):517-9. PubMed ID: 18422762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schwannomatosis: the overlooked neurofibromatosis?
    Koontz NA; Wiens AL; Agarwal A; Hingtgen CM; Emerson RE; Mosier KM
    AJR Am J Roentgenol; 2013 Jun; 200(6):W646-53. PubMed ID: 23701098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?
    Leverkus M; Kluwe L; Röll EM; Becker G; Bröcker EB; Mautner VF; Hamm H
    Br J Dermatol; 2003 Apr; 148(4):804-9. PubMed ID: 12752143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schwannomatosis: a Realm Reborn: year one.
    Planet M; Kalamarides M; Peyre M
    Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of peripheral nerve schwannomas.
    El Sayed L; Masmejean EH; Parfait B; Kalamarides M; Biau D; Peyre M
    Acta Neurochir (Wien); 2020 Aug; 162(8):1883-1889. PubMed ID: 32556523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schwannomatosis of the sciatic nerve: a case report.
    Erdoğan F; Say F; Barış YS
    Br J Neurosurg; 2023 Feb; 37(1):100-103. PubMed ID: 34275400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognizing schwannomatosis and distinguishing it from neurofibromatosis type 1 or 2.
    Westhout FD; Mathews M; Paré LS; Armstrong WB; Tully P; Linskey ME
    J Spinal Disord Tech; 2007 Jun; 20(4):329-32. PubMed ID: 17538359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Schwannoma, Neurofibromatosis Type 2, and Schwannomatosis in the 2021 WHO Classification of Tumors of the Central Nervous System].
    Nagai K; Fujii M
    No Shinkei Geka; 2023 Sep; 51(5):845-857. PubMed ID: 37743336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
    Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
    J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study.
    Evans DG; Mason S; Huson SM; Ponder M; Harding AE; Strachan T
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):361-6. PubMed ID: 9120449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.
    Smith MJ; Kulkarni A; Rustad C; Bowers NL; Wallace AJ; Holder SE; Heiberg A; Ramsden RT; Evans DG
    Am J Med Genet A; 2012 Jan; 158A(1):215-9. PubMed ID: 22105938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
    Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
    J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of schwannomatosis: a retrospective analysis of 87 patients.
    Merker VL; Esparza S; Smith MJ; Stemmer-Rachamimov A; Plotkin SR
    Oncologist; 2012; 17(10):1317-22. PubMed ID: 22927469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
    Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
    Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.